Phase III Observational Trial: Synthetic Contrast-Enhanced MRI vs Standard Contrast MRI for Breast Cancer Diagnosis — What Radiologists Need to Know

References

1. 1.Peking University People's Hospital. (2024). Development and Clinical Validation of a Diffusion-Weighted Imaging-Based Synthetic Contrast-Enhanced MRI System for Non-Contrast Breast Cancer Diagnosis and Risk Stratification. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07598084
2. 2.Kuhl, C. K. (2023). Abbreviated breast MRI for screening women with dense breasts. Radiology, 308(2), e230334. https://doi.org/10.1148/radiol.230334
3. 3.McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2023). Gadolinium deposition in human brain tissues after contrast-enhanced MRI. Radiology, 307(3), e221659. https://doi.org/10.1148/radiol.2023221659
4. 4.Baltzer, P., Mann, R. M., Iima, M., Sigmund, E. E., Clauser, P., Gilbert, F. J., Martincich, L., Partridge, S. C., Patterson, A., Pinker, K., Thibault, F., Camps-Herrero, J., & Le Bihan, D. (2023). Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. European Radiology, 33(7), 4696-4717. https://doi.org/10.1007/s00330-023-09946-x
5. 5.Partridge, S. C., Nissan, N., Rahbar, H., Kitsch, A. E., & Sigmund, E. E. (2023). Diffusion-weighted breast MRI: Clinical applications and emerging techniques. Journal of Magnetic Resonance Imaging, 57(4), 1102-1120. https://doi.org/10.1002/jmri.28569
6. 6.Mann, R. M., Cho, N., & Moy, L. (2023). Breast MRI: State of the art. Radiology, 306(2), e220541. https://doi.org/10.1148/radiol.220541
7. 7.Gulani, V., Calamante, F., Shellock, F. G., Kanal, E., & Reeder, S. B. (2023). Gadolinium deposition in the brain: summary of evidence and recommendations. The Lancet Neurology, 22(6), 533-544. https://doi.org/10.1016/S1474-4422(23)00021-3
8. 8.Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2023). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 73(3), 233-254. https://doi.org/10.3322/caac.21834